Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ototoxicity and topical eardrops

J Marais1, J A Rutka

  • 1Otolaryngology Unit, University of Edinburgh, Royal Infirmary, UK.

Clinical Otolaryngology and Allied Sciences
|October 8, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case study: Boomslang envenomation in North-Eastern South Africa.

Toxicon : official journal of the International Society on Toxinology·2023
Same author

The Rare Case of an Adult-Onset Xanthogranuloma of the Paranasal Sinuses: A Histological Dilemma.

Case reports in pathology·2020
Same author

Gauging the effectiveness of canal occlusion surgery: how I do it.

The Journal of laryngology and otology·2019
Same author

Clipping of sigmoid sinus diverticulum: how I do it.

The Journal of laryngology and otology·2018
Same author

Internal carotid artery aneurysm in skull base osteomyelitis: does the pattern of cranial nerve involvement matter?

The Journal of laryngology and otology·2018
Same author

Optimising perioperative care for hip and knee arthroplasty in South Africa: a Delphi consensus study.

BMC musculoskeletal disorders·2018
Same journal

Correspondence.

Clinical otolaryngology and allied sciences·2017
Same journal

Erratum.

Clinical otolaryngology and allied sciences·2013
Same journal

Compact training course in ear surgery erlangen, Germany, 26-28 february 1998.

Clinical otolaryngology and allied sciences·2013
Same journal

How we do it: a practical approach to Foley catheter posterior nasal packing.

Clinical otolaryngology and allied sciences·2004
Same journal

How we do it: management of tracheobronchial foreign bodies in children.

Clinical otolaryngology and allied sciences·2004
Same journal

Is cochlear outer hair cell function affected by mobile telephone radiation?

Clinical otolaryngology and allied sciences·2004
See all related articles

Topical aminoglycoside ear drops, like Garasone, can cause rare but severe vestibular ototoxicity when the eardrum is perforated. This risk highlights the need for caution with these ear treatments.

Area of Science:

  • Ototolaryngology
  • Pharmacology
  • Neuroscience

Background:

  • Topical aminoglycoside ear drops are considered potentially ototoxic if used with a perforated tympanic membrane.
  • Clinical ototoxicity from these drops is generally considered rare.

Observation:

  • This study presents nine new cases (12 ears) of iatrogenic topical vestibulotoxicity from prolonged use of Garasone (gentamicin and betamethasone).
  • This represents the largest reported series of such cases in the English literature.
  • Five previously reported cases and four additional new cases of topical ototoxicity were also reviewed.

Findings:

  • The observed toxicity was predominantly vestibular, affecting balance, rather than cochlear, affecting hearing.
  • While unilateral cases showed compensation, bilateral cases resulted in severe disability.

Related Experiment Videos

  • The findings suggest a significant risk of vestibular damage from topical gentamicin in perforated ears.
  • Implications:

    • Clinicians should exercise extreme caution when prescribing topical aminoglycoside ear drops, especially Garasone, in patients with tympanic membrane perforations.
    • The potential for severe, permanent vestibular dysfunction necessitates careful patient selection and monitoring.
    • These findings may influence prescribing guidelines and patient counseling regarding the risks of topical ototoxicity.